Silod, Kienzces Paul E.

HRN: 17-25-56  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2022
CEFUROXIME 1.5GM (VIAL)
09/24/2022
09/30/2022
IV
1.5gm
Q8
T/C Acute Appendicitis
Waiting Final Action 
09/24/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/24/2022
09/30/2022
IV
500mg
Q8
T/C Acute Appendicitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: